The second wave in kinase cancer drugs.
Garber
Ken
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010597:Pharmacogenetics / Q000639:trends*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D014481:United States
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors